Panagora Asset Management Inc Alkermes Plc. Transaction History

Panagora Asset Management Inc

  • $19.6 Billion
  • Q1 2025

A detailed history of Panagora Asset Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 859,982 shares of ALKS stock, worth $24.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
859,982
Previous 862,140 0.25%
Holding current value
$24.8 Million
Previous $24.8 Million 14.52%
% of portfolio
0.14%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$28.08 - $36.0 $60,596 - $77,688
-2,158 Reduced 0.25%
859,982 $28.4 Million
Q4 2024

Feb 13, 2025
SELL
$25.7 - $31.46 $14,392 - $17,617
-560 Reduced 0.06%
862,140 $24.8 Million
Q3 2024

Nov 13, 2024
BUY
$23.01 - $28.55 $44,478 - $55,187
1,933 Added 0.22%
862,700 $24.1 Million
Q2 2024

Jul 29, 2024
BUY
$23.21 - $27.24 $2.27 Million - $2.67 Million
97,921 Added 12.84%
860,767 $20.7 Million
Q1 2024

May 07, 2024
SELL
$26.4 - $32.56 $523,010 - $645,046
-19,811 Reduced 2.53%
762,846 $20.7 Million
Q4 2023

Feb 08, 2024
SELL
$23.37 - $28.68 $126,338 - $155,044
-5,406 Reduced 0.69%
782,657 $21.7 Million
Q3 2023

Oct 31, 2023
SELL
$27.17 - $31.97 $69,609 - $81,907
-2,562 Reduced 0.32%
788,063 $22.1 Million
Q2 2023

Aug 11, 2023
SELL
$28.34 - $33.63 $839,600 - $996,322
-29,626 Reduced 3.61%
790,625 $24.7 Million
Q1 2023

May 11, 2023
BUY
$25.31 - $29.02 $675,296 - $774,282
26,681 Added 3.36%
820,251 $23.1 Million
Q4 2022

Feb 13, 2023
BUY
$21.94 - $26.24 $992,938 - $1.19 Million
45,257 Added 6.05%
793,570 $20.7 Million
Q3 2022

Nov 14, 2022
BUY
$22.0 - $31.87 $321,816 - $466,194
14,628 Added 1.99%
748,313 $16.7 Million
Q2 2022

Aug 15, 2022
BUY
$26.4 - $30.54 $2.5 Million - $2.89 Million
94,645 Added 14.81%
733,685 $21.9 Million
Q1 2022

May 12, 2022
BUY
$23.07 - $27.99 $537,600 - $652,250
23,303 Added 3.78%
639,040 $16.8 Million
Q4 2021

Feb 10, 2022
BUY
$21.47 - $32.08 $1.8 Million - $2.69 Million
83,742 Added 15.74%
615,737 $14.3 Million
Q3 2021

Nov 10, 2021
BUY
$23.37 - $32.13 $1.39 Million - $1.91 Million
59,318 Added 12.55%
531,995 $16.4 Million
Q2 2021

Aug 11, 2021
BUY
$18.78 - $25.15 $8.76 Million - $11.7 Million
466,285 Added 7294.82%
472,677 $11.6 Million
Q1 2021

May 12, 2021
BUY
$18.21 - $23.2 $99,790 - $127,136
5,480 Added 600.88%
6,392 $119,000
Q4 2020

Feb 10, 2021
SELL
$15.39 - $22.1 $7,941 - $11,403
-516 Reduced 36.13%
912 $18,000
Q3 2020

Nov 13, 2020
SELL
$16.16 - $20.66 $2.01 Million - $2.57 Million
-124,173 Reduced 98.86%
1,428 $24,000
Q2 2020

Aug 12, 2020
SELL
$13.31 - $19.41 $2.11 Million - $3.08 Million
-158,752 Reduced 55.83%
125,601 $2.44 Million
Q1 2020

May 14, 2020
BUY
$13.06 - $21.24 $456,316 - $742,125
34,940 Added 14.01%
284,353 $4.1 Million
Q4 2019

Feb 12, 2020
BUY
$17.29 - $21.74 $350,969 - $441,300
20,299 Added 8.86%
249,413 $5.09 Million
Q3 2019

Nov 12, 2019
BUY
$19.51 - $24.28 $4.05 Million - $5.04 Million
207,628 Added 966.34%
229,114 $4.47 Million
Q2 2019

Aug 09, 2019
BUY
$21.47 - $37.33 $421,176 - $732,302
19,617 Added 1049.6%
21,486 $485,000
Q4 2018

Feb 14, 2019
BUY
$27.94 - $44.61 $29,867 - $47,688
1,069 Added 133.63%
1,869 $55,000
Q3 2018

Nov 13, 2018
SELL
$38.6 - $46.12 $2,856 - $3,412
-74 Reduced 8.47%
800 $34,000
Q4 2017

Feb 14, 2018
SELL
$47.69 - $55.39 $481,239 - $558,940
-10,091 Reduced 92.03%
874 $48,000
Q3 2017

Nov 14, 2017
BUY
$49.16 - $54.45 $539,039 - $597,044
10,965
10,965 $557,000

Others Institutions Holding ALKS

# of Institutions
409
Shares Held
177M
Call Options Held
229K
Put Options Held
436K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.74B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email